Deborah Abrams Kaplan writes on medical, health, healthcare, healthcare IT, healthcare tech, cancer, personal finance, business, supply chain, insurance, blockchain and COVID-19.
How Section 321 Can Reduce Your Fulfillment Costs
Companies, especially eCommerce retailers, are under a lot of financial pressure. Not only are they competing against other brands in getting eyes on their products, but fulfillment and shipping costs are a huge factor in determining margins and sales success. Charge the buyer too much for shipping and they will buy from the competitor. Charge too little, and the retailer loses money. And if the eCommerce retailer offers free shipping, the financial stakes can be even higher.
What Does Dynamic Pricing Mean for FedEx and UPS?
Whether you know it or not, you’re already familiar with the concept of dynamic pricing. FedEx, UPS, shipping, supply chain, logistics, 3PL
Why the Mayo Clinic commercialized its supply chain services
When it comes to healthcare supply chains, the Mayo Clinic believes that it is better to collaborate than compete with other organizations, Bruce Mairose, division chair of supply chain management sourcing and networks, told Supply Chain Dive. It works with Vizient, HumanityCorp, Captis and Inspirity Health Partners to save on medical supplies, transportation and business services.
Why DIY? Hospitals Are Outsourcing Clinical, Nonclinical Services
Outsourcing hospital and health services can either be the greatest business move or the worst, depending on whom you talk to and how well it’s done. But one thing seems clear: Outsourcing is gaining popularity. The global hospital outsourcing market is anticipated to grow from $375.1 billion in 2023 to $612.24 billion in 2027, a 14.4% compound annual growth rate, according to Research and Markets, and North America was the largest hospital outsourcing market in 2022.
What’s the state of parental leave in manufacturing?
Lorie Wilson had her first daughter Paige, when she worked at an auto components manufacturer in 1997, followed by her second, Rachel, in 2000. The collective bargaining agreement for the unionized company included six weeks of partial-pay maternity leave under short term disability, worth roughly 60% of her typical wages. Her husband, Terry, who worked at the same plant, received no paid leave.
parental leave, women in manufacturing, benefits, maternity
2023 healthcare halftime report
6 healthcare hot topics to keep an eye on for 2023 and 2024. Medicare, transparency, pricing, PBM legislation, pharmacy, drug shortages
How Henry Ford Health uses data to combat inflation and improve its supply chain
While inflation is an ongoing concern for hospitals nationwide, the Detroit-based non-profit Henry Ford Health managed to bring its supply expenses down last year, a fact that Senior VP of Supply Chain Management Bill Moir takes pride in.
supply chain, health system, healthcare, hospital
Reality Check on Alternative Payment Methods
The CMS Innovation Center has launched more than 50 alternative payment models (APMs) since it was established in 2010 as part of the Affordable Care Act. The models have involved approximately 28 million patients and half a million providers and plans, and all signs point to expanding the concept. The CMS Innovation Center announced in 2021 that it wanted every Medicare member with Part A and B coverage to be in a healthcare relationship with accountability for quality and total cost of care.
Pharmaceutical supply chains raise data concerns as traceability law nears final step
A decade-long regulatory deadline is looming for the pharmaceutical supply chain to electronically share drug data from end-to-end, or risk healthcare ecosystem instability.
Drug distribution, pharmaceutical distribution, DSCSA, Drug Supply Chain Security Act, cybersecurity, pharma
How Allina Health is rethinking supply chain spend
It’s one thing to have supply chain experts sitting at their desks and talking with suppliers. It’s another to be in the room when supplies are being used, and evaluating what is truly needed. Allina Health, a major metropolitan healthcare system in Minnesota and Wisconsin, is putting supply chain procedure specialists in the operating room...
Physicians Band Together to Fend Off Private-Equity Firms
Marco Fernandez, M.D., says he was blindsided in 2021 when his anesthesiology group, Midwest Anesthesia Partners in Arlington Heights, Illinois, lost two hospital contracts in two weeks to private equity-owned anesthesiology groups. What was more surprising to Fernandez, the group’s president, was that the person contracting on behalf of the private-equity group was an executive board member for the American Society of Anesthesiologists. “I was in disbelief,” Fernandez said.
healthcare, physician, private equity, healthcare management
Addressing Disparities in Healthcare: What Cardiologists Can Do
Local physician roundtables don't usually make news or capture the attention of thousands of social media users. But a physician roundtable in California did just that, with a striking anecdotal example of how patients experience harm when provider biases aren't recognized.1 It can result in delayed diagnostic cardiac testing or worse —treatment delays or the absence of treatment and highlights the disparities in healthcare.
In the video (around timestamp 1:15:55) of the roundtable hosted by ...
Designing an innovative partnership
How Deloitte and SCAD's dynamic partnership offers students real-world experience they can't get elsewhere.
College, education, film, TV, design, consulting, public service
Successfully Engaging Physicians in Value Analysis
Getting doctors involved is a crucial component of a value analysis team
While a physician’s first priority is optimal patient care, infrastructure behind the scenes is critical to ensuring that can occur. Medical supplies and devices have an associated cost, and some provide better value than others. That’s where a value analysis team (VAT) provides support.
Unique Combinations to Optimize CAR T-Cell Therapy in Hematologic Malignancies
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized treatment in the hematologic malignancy space, but it has a long way to go to effectively treat the many hematologic cancers. That is because it faces obstacles such as lengthy manufacturing time, patient access, adverse events, and variable efficacy.
oncology, hematology, cancer, CAR T,